Rituximab Induced Remission in Patients With Chronic Inflammatory Demyelinating Polyneuropathy
Clinical trial NCT06714838 · RECRUITING
Trial details
- NCT number
- NCT06714838
- Sponsor
- Amsterdam University Medical Center (UMC), Location Academic Medical Center (AMC)
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-16
- Primary completion
- 2027-10-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.